According to Chinese medicine, the liver is mainly responsible for facilitating digestion and absorption, as well as maintaining the flow of Qi, blood and fluids. The liver is also responsible for the flow of qi, blood and fluids. The liver can cleanse the body of waste, destroy toxic substances, participate in digestion and absorption, and coordinate its mental and emotional activities.
"Eat"
-
-
Apparatus
New Study Reveals Antibiotic Abuse For Sore Throats Pushes Up The Third Leading Cause Of Death Worldwide
Misconceptions about how to treat a sore throat are fuelling the overuse of antibiotics, according to STAR research.
-
Prior to the granting of marketing authorisation by the MHRA, Biyze® had been approved by the European Commission for a number of indications and is currently the only drug approved for the treatment of MZL in Great Britain.
-
Every disease has a cause, and we are all sick because of various factors. Understanding the causes of diseases can help us to prevent them, which will help our health a lot.
-
Medical
New Treatment For Uroepithelial Carcinoma Receives Fda Fast Track Designation With Encouraging Initial Results
The FDA granted Fast Track designation to a new drug, IK-175, in combination with nabumab for the treatment of advanced uroepithelial carcinoma, after preliminary trial data showed encouraging and durable anti-tumor activity with a favorable safety profile.
-
There are many diseases that may recur after treatment, so many head and neck cancer patients are worried about such a situation, and their frequent ruminations may cause a lot of psychological stress to them.
-
Great Ormond Street Hospital for Children is a world-renowned children's hospital with a long history. It is recognised as one of the few international paediatric centres in the world that can treat children with rare, complex or multiple conditions.
-
When it comes to hemorrhoids, many people probably think of the fierce, unspeakable, restless pain
-
Medical
Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma
Pfizer's new treatment, Elranatamab, has received Breakthrough Therapy designation from the FDA for the treatment of patients with relapsed or refractory multiple myeloma. Data from the trial showed a patient efficacy rate of 61.0% and that once the therapy is effective, efficacy is maintained for more than six months in over 90% of patients!
-
Food is the most important thing for people, but do you know what to eat more? What to eat less or not? When should I eat it? When should I not eat?